US 11179328
Compositions and methods for the treatment of presbyopia
granted A61KA61K31/439A61K31/4409
Quick answer
US patent 11179328 (Compositions and methods for the treatment of presbyopia) held by Lenz Therapeutics, Inc. expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lenz Therapeutics, Inc.
- Grant date
- Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/439, A61K31/4409, A61K45/06, A61K47/02